DOI QR코드

DOI QR Code

Radiofrequency Thermal Ablation in Painful Myeloma of the Clavicle

  • Gharaei, Helen (Department of Anesthesiology and Pain Medicine, Amirmomenin Hospital, Tehran Azad Islamic University of Medical Science) ;
  • Imani, Farnad (Anesthesiology and Pain Department, Rasoul-Akram Hospital, Tehran University of Medical Sciences) ;
  • Vakily, Masoud (Hematology and Oncology Department, Rasoul-Akram Hospital, Tehran University of Medical Sciences)
  • Received : 2013.09.13
  • Accepted : 2013.11.18
  • Published : 2014.01.01

Abstract

A 57-year-old male patient had myeloma. He had severe pain in the left clavicle that did not respond to radiotherapy; therefore, it was treated with radiofrequency thermal ablation (RFTA). Under fluoroscopic guidance, two RF needles at a distance of 1.5 cm from each other were inserted into the mass and conventional radiofrequency ($90^{\circ}C$ and 60 seconds) at two different depths (1 cm apart) was applied. Then, 2 ml of 0.5% ropivacaine along with triamcinolone 40 mg was injected in each needle. The visual analogue pain score (VAS from 0 to 10) was decreased from 8 to 0. In the next 3 months of follow-up, the patient was very satisfied with the procedure and the mass gradually became smaller. There were no complications. This study shows that RFTA could be a useful method for pain management in painful osteolytic myeloma lesions in the clavicle

Keywords

References

  1. Rajkumar SV. Plasma cell disorders. In: Goldman's cecil medicine. 24th ed. Edited by Goldman L, Schafer AI. Philadelphia (PA), Elsevier Saunders. 2012, pp 1237-40.
  2. Munshi NC, Longo DL, Anderson KC. Plasma cell disorders. In: Harrison's principle of internal medicine. 18th ed. Edited by Longo DL, Fauci AS, Kasper DL, Hauser SL, Jameson JL, Loscalzo J. New York (NY), McGraw-Hill, Medical. 2012, pp 941-2.
  3. Janjan NA. Radiation for bone metastases: conventional techniques and the role of systemic radiopharmaceuticals. Cancer 1997; 80(8 Suppl): 1628-45. https://doi.org/10.1002/(SICI)1097-0142(19971015)80:8+<1628::AID-CNCR13>3.0.CO;2-1
  4. Tharmalingam S, Chow E, Harris K, Hird A, Sinclair E. Quality of life measurement in bone metastases: a literature review. J Pain Res 2008; 1: 49-58.
  5. Schaefer O, Lohrmann C, Herling M, Uhrmeister P, Langer M. Combined radiofrequency thermal ablation and percutaneous cementoplasty treatment of a pathologic fracture. J Vasc Interv Radiol 2002; 13: 1047-50. https://doi.org/10.1016/S1051-0443(07)61872-7
  6. Jeremic B, Shibamoto Y, Acimovic L, Milicic B, Milisavljevic S, Nikolic N, et al. A randomized trial of three single-dose radiation therapy regimens in the treatment of metastatic bone pain. Int J Radiat Oncol Biol Phys 1998; 42: 161-7.
  7. Helmberger TK. Radiofrequency ablation. In: Percutaneous tumor ablation in medical radiology. Edited by Vogl TJ, Helmberger TK, Mack MG, Reiser MF. Berlin, Springer. 2008, pp 7-11.
  8. de Baere T, Elias D, Dromain C, Din MG, Kuoch V, Ducreux M, et al. Radiofrequency ablation of 100 hepatic metastases with a mean follow-up of more than 1 year. AJR Am J Roentgenol 2000; 175: 1619-25. https://doi.org/10.2214/ajr.175.6.1751619
  9. Oprée A, Kress M. Involvement of the proinflammatory cytokines tumor necrosis factor-alpha, IL-1 beta, and IL-6 but not IL-8 in the development of heat hyperalgesia: effects on heat-evoked calcitonin gene-related peptide release from rat skin. J Neurosci 2000; 20: 6289-93.
  10. Mantyh PW, Clohisy DR, Koltzenburg M, Hunt SP. Molecular mechanisms of cancer pain. Nat Rev Cancer 2002; 2:201-9. https://doi.org/10.1038/nrc747
  11. Caraceni A, Martini C, Zecca E, Portenoy RK, Ashby MA, Hawson G, et al. Breakthrough pain characteristics and syndromes in patients with cancer pain. An international survey. Palliat Med 2004; 18: 177-83. https://doi.org/10.1191/0269216304pm890oa
  12. Delaney A, Fleetwood-Walker SM, Colvin LA, Fallon M. Translational medicine: cancer pain mechanisms and management. Br J Anaesth 2008; 101: 87-94. https://doi.org/10.1093/bja/aen100
  13. Colvin L, Fallon M. Challenges in cancer pain management-- bone pain. Eur J Cancer 2008; 44: 1083-90. https://doi.org/10.1016/j.ejca.2008.03.001
  14. Smith HS, Mohsin I. Painful boney metastases. Korean J Pain 2013; 26: 223-41. https://doi.org/10.3344/kjp.2013.26.3.223
  15. Callstrom MR, Charboneau JW. Image-guided palliation of painful metastases using percutaneous ablation. Tech Vasc Interv Radiol 2007; 10: 120-31. https://doi.org/10.1053/j.tvir.2007.09.003
  16. Dupuy DE, Liu D, Hartfeil D, Hanna L, Blume JD, Ahrar K, et al. Percutaneous radiofrequency ablation of painful osseous metastases: a multicenter American College of Radiology Imaging Network trial. Cancer 2010; 116: 989-97. https://doi.org/10.1002/cncr.24837
  17. Simon CJ, Dupuy DE. Percutaneous minimally invasive therapies in the treatment of bone tumors: thermal ablation. Semin Musculoskelet Radiol 2006; 10: 137-44. https://doi.org/10.1055/s-2006-939031
  18. Goetz MP, Callstrom MR, Charboneau JW, Farrell MA, Maus TP, Welch TJ, et al. Percutaneous image-guided radiofrequency ablation of painful metastases involving bone: a multicenter study. J Clin Oncol 2004; 22: 300-6. https://doi.org/10.1200/JCO.2004.03.097
  19. Santiago FR, Del Mar Castellano García M, Montes JL, García MR, Fernández JM. Treatment of bone tumours by radiofrequency thermal ablation. Curr Rev Musculoskelet Med 2009; 2: 43-50. https://doi.org/10.1007/s12178-008-9042-3
  20. Carrafiello G, Laganà D, Ianniello A, Nicotera P, Fontana F, Dizonno M, et al. Radiofrequency thermal ablation for pain control in patients with single painful bone metastasis from hepatocellular carcinoma. Eur J Radiol 2009; 71: 363-8. https://doi.org/10.1016/j.ejrad.2008.04.019